Product Description

Product Description
This digital document is an article from Family Practice News, published by Thomson Gale on January 15, 2007. The length of the article is 665 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Parkinson's drugs associated with valvular disease.(News)
Author: Betsy Bates
Publication: Family Practice News (Magazine/Journal)
Date: January 15, 2007
Publisher: Thomson Gale
Volume: 37Issue: 2Page: 6(1)

Distributed by Thomson Gale ... Read more

Product Description
This digital document is an article from Internal Medicine News, published by International Medical News Group on January 1, 2005. The length of the article is 600 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: High prevalence of valvular disease found in the elderly.(Cardiovascular Medicine)
Author: Mitchel L. Zoler
Publication: Internal Medicine News (Magazine/Journal)
Date: January 1, 2005
Publisher: International Medical News Group
Volume: 38Issue: 1Page: 50(1)

Distributed by Thomson Gale ... Read more

Product Description

Infective endocarditis is a condition that still carries a high morbidity and mortality rate (20-30%) despite modern antibiotics and surgical treatment. The infection, usually caused by bacteria, invades the innermost lining of the heart and can damage heart valves, connective tissue and the heart chambers themselves. Rapid diagnosis, effective treatment, and prompt recognition of complications are essential to good patient outcome. If untreated, mortality is extremely high. The prevalence of infective endocarditis is between 1.7 and 4 people per 100,000, and is most commonly found in people who have underlying heart disease. Symptoms can be as non-specific as fever, fatigue, weight loss, new rashes (either painful or painless), headaches, backaches, joint pains and confusion; hence the disease remains a diagnostic and therapeutic challenge. Effective therapy has become progressively more difficult to achieve because of the proliferation of implanted biomechanical devices and the rise in the number of resistant organisms.